Insular Thyroid Cancer
5 clinical trials · Condition
◉ Watch Insular Thyroid Cancer
| Record | Firm | Date |
|---|---|---|
| Dabrafenib With or Without Trametinib in Treating Patients With Advanced Differentiated Thyroid Cancer (NCT01723202) | Bhavana Konda | 2012-11-07 |
| Suberoylanilide Hydroxamic Acid in Treating Patients With Metastatic and/or Locally Advanced or Locally Recurrent Thyroid Cancer (NCT00134043) | National Cancer Institute (NCI) | 2005-12-01 |
| Bortezomib in Treating Patients With Metastatic Thyroid Cancer That Did Not Respond to Radioactive Iodine Therapy (NCT00104871) | National Cancer Institute (NCI) | 2004-12-01 |
| Sorafenib Tosylate in Treating Patients With Locally Advanced, Metastatic, or Locally Recurrent Thyroid Cancer (NCT00095693) | National Cancer Institute (NCI) | 2004-10-01 |
| Gefitinib in Treating Patients With Metastatic or Unresectable Head and Neck Cancer or Non-Small Cell Lung Cancer (NCT00068497) | National Cancer Institute (NCI) | 2003-08-01 |
Track Insular Thyroid Cancer automatically
Every clearance here is in the API, with alerts when new ones post.